Xarelto Lawsuit Plaintiffs Note Investigation Surrounding Potentially Invalid Trial Results Due To Defective Device

March 21, 2016 – – BloodThinnerHelp.com announces details from a report published by Reuters detailing an investigation by U.S. and European drug regulators which has been started in order to determine whether a defective blood clotting test device may have impacted trial results conducted on new-generation anticoagulant Xarelto.

Xarelto is the topic of much recent controversy as the drug is currently the subject of over 3,400 lawsuits. These lawsuits were filed by plaintiffs from across the country who share common allegations that the drug can cause heightened risk of sudden and dangerous bleeding episodes among patients, some of which have been fatal. The lawsuits have formed two main groups: MDL number 2592 in Eastern Louisiana, where more than 2,800 cases have been transferred, and more than 600 cases which have been formed into a mass tort program in Philadelphia, Pennsylvania by the Court of Common Pleas.

The trial now being investigated was conducted in order to compare the clotting effects of Xarelto to those of traditional blood thinner warfarin. Researchers conducting the studies were asked to evaluate the overall effectiveness of each drug in preventing strokes among patients with atrial fibrillation. Since the trial was completed, however, it has been discovered that one of the pieces of medical equipment used was recalled and was potentially faulty.

European Medicines Agency officials discussed this possibility, noting, “Due to the defect, it is now thought that the INR (international normalized ration) device may have impacted the clotting results in some patients in the warfarin group,” They also announced that they would not publish any of the trial’s results until the investigation concerning the accuracy of those results had finished. The medical device in question is called an INR. It works to measure how quickly blood is able to clot. It has been indicated that the device used during this study was recalled in December of 2014.

Plaintiffs currently involved in the Xarelto cases are awaiting trial, and lawsuit numbers continue to grow as time moves on. Attorney Joseph Osborne is working to ensure that anyone who feels they were negatively affected by Xarelto will be given the important opportunity to fully explore their legal rights in the matter. Patients who took Xarelto and also suffered from health problems could be entitled to significant compensation gained through legal action. To help assist those wishing to pursue justice, Attorney Osborne is now offering free Xarelto consultations to affected parties.

To request additional Xarelto lawsuit information, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008801